搜索临床试验以:PL1
总计1578个结果
-
The George InstituteNational Health and Medical Research Council, Australia完全的
-
Janssen Research & Development, LLC完全的
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLC招聘中铂耐药卵巢癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类难治性输卵管癌 | 铂类难治性原发性腹膜癌 | 铂类难治性卵巢癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感性卵巢癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感性输卵管癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感原发性腹膜癌美国, 芬兰
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)招聘中
-
Emory UniversityNational Cancer Institute (NCI); Xencor, Inc.招聘中
-
R-Pharm International, LLCIQVIA RDS Ireland Ltd; Thermo Fisher Scientific FS完全的
-
Duke UniversityFood and Drug Administration (FDA)招聘中
-
Boston UniversityBrown University; University of Michigan; Centers for Disease Control and Prevention完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的心脏疾病 | 心血管疾病 | 血管疾病 | 动脉闭塞性疾病 | 糖尿病
-
Daiichi SankyoMerck Sharp & Dohme LLC招聘中
-
Fred Hutchinson Cancer CenterSignalOne Bio, Inc.终止转移性肺非小细胞癌 | 解剖学 IV 期乳腺癌 AJCC v8 | IV 期肺癌 AJCC v8 | 转移性恶性实体瘤 | 转移性尿路上皮癌 | 转移性三阴性乳腺癌美国
-
Hoffmann-La Roche主动,不招人
-
Daiichi Sankyo, Inc.Medpace, Inc.完全的
-
Zhejiang UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; Second Affiliated Hospital, School... 和其他合作者未知
-
AbbVieBoehringer Ingelheim完全的
-
University of South FloridaNational Cancer Institute (NCI)终止
-
Regeneron PharmaceuticalsSanofi完全的